| Pharmaceutical active ingredients: |
| Sulfachloropyrazine Sodium Monohydrate |
| Available forms, composition and doses of Coxisol: |
| Powder for Solution; Oral; Sulfachloropyrazine Sodium Monohydrate 30% |
| Coxisol medical category: |
| Veterinary; Pet Meds |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ocusol | Sulfacetamide Sodium; Zinc Sulfate | Boots |
| Zinco Sulpha | Sulfacetamide Sodium; Zinc Sulfate | Bell Pharma |
| Sultrin Triple Sulfa | Sulfacetamide; Sulfanilylbenzamide; Sulfathiazole; Urea | Ortho McNeil Pharmaceuticals |
| Locion Axel | Sulfacetamide; Sulfur | Grisi Hermanos Laboratorios |
| S.C.P 47 | Sulfachloropyrazine | Teva |
| ESB 3 | Sulfachloropyrazine Sodium Monohydrate | Novartis |
| S.C.P. Gal | Sulfachloropyrazine Sodium Monohydrate | Galpharma Pharmaceutical |
| Cluricol | Sulfachlorpyridazine | Unidentified Pharmaceutical Company |
| Durasulf | Sulfachlorpyridazine | Unidentified Pharmaceutical Company |
| Nefrosul | Sulfachlorpyridazine | Unidentified Pharmaceutical Company |